Anthem Biosciences IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 3395.00 Cr. The company is based in Bangalore and caters to Pharmaceutical sector. Citigroup Global Markets India , J.P. Morgan India , Jm Financial , Nomura Financial Advisory And Securities (India) are the merchant bankers of Anthem Biosciences IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 31st December 2024.
Anthem Biosciences IPO open date is 14th July 2025 and close date is 16th July 2025. IPO Allotment Date is 17th July 2025 and Listing date is 21st July 2025.Anthem Biosciences IPO size is ₹ 3395.00 Cr. with IPO price of ₹ 570.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Citigroup Global Markets India Private Limited is the book-running lead manager of the Anthem Biosciences IPO. Kfin Technologies Limited is the Registrar for Anthem Biosciences IPO.
Anthem Biosciences IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Anthem Biosciences IPO, based in Bangalore, operates in the Pharmaceutical sector with a focus on an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization. The company is launching its MainBoard Upcoming IPO on the BSE,NSE exchange, using the Book Building Issue method. Anthem Biosciences IPO size is ₹ 3395.00 Cr. with fresh issue size of ₹ [●] and Offer for sale being ₹ 3395.00 Cr.
The IPO allotment date for Anthem Biosciences IPO is expected to be 17th July 2025, after the finalization of basis of allotment. Investors can check Anthem Biosciences IPO allotment status on the registrars website, Kfin Technologies Limited . Anthem Biosciences IPO refund dates are 18th July 2025.
Anthem Biosciences IPO is expected to be listed on 21st July 2025.
The upper price band for the Anthem Biosciences IPO is set at ₹ 570.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Anthem Biosciences IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Anthem Biosciences IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 16th July 2025. After submission, funds are blocked until the basis of allotment of Anthem Biosciences IPO is finalised.
The merchant banker for Anthem Biosciences IPO is Citigroup Global Markets India Private Limited , J.P. Morgan India Private Limited , Jm Financial Limited , Nomura Financial Advisory And Securities (India) Private Limited . Citigroup Global Markets India Private Limited , J.P. Morgan India Private Limited , Jm Financial Limited , Nomura Financial Advisory And Securities (India) Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Anthem Biosciences IPO RHP for further details.
The registrar for Anthem Biosciences IPO is Kfin Technologies Limited . Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Anthem Biosciences IPO through their official website or helpline.
Anthem Biosciences IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Anthem Biosciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Anthem Biosciences Financial Review Page
Merchant Banker(s) of Anthem Biosciences IPO: Citigroup Global Markets India Private Limited , J.P. Morgan India Private Limited , Jm Financial Limited , Nomura Financial Advisory And Securities (India) Private Limited
Anthem Biosciences IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Anthem Biosciences IPO listed at a listing price of against the offer price of 570.00.
The current market price of Anthem Biosciences is .
Why Us?